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Summary
The peroxisome-biogenesis disorders (PBDs) are a group
of genetically heterogeneous, lethal diseases that are
characterized by neuronal, hepatic, and renal abnor-
malities; severe mental retardation; and, in their most
severe form, death within the 1st year of life. Cells from
all PBD patients exhibit decreased import of one or more
classes of peroxisome matrix proteins, a phenotype
shared by yeast pex mutants. We identified the human
orthologue of yeast PEX10 and observed that its ex-
pression rescues peroxisomal matrix-protein import in
PBD patients’ fibroblasts from complementation group
7 (CG7). In addition, we detected mutations on both
copies of PEX10 in two unrelated CG7 patients. A Zell-
weger syndrome patient, PBD100, was homozygous for
a splice donor–site mutation that results in exon skip-
ping and loss of 407 bp from the PEX10 open reading
frame. A more mildly affected neonatal adrenoleuko-
dystrophy patient was a compound heterozygote for a
missense mutation in the PEX10 zinc-binding domain,
H290Q, and for a nonsense mutation, R125ter. Al-
though all three mutations attenuate PEX10 activity, the
two alleles detected in the mildly affected patient,
PBD052, encode partially functional PEX10 proteins.
PEX10-deficient PBD100 cells contain many peroxi-
somes and import peroxisomal membrane proteins but
do not import peroxisomal matrix proteins, indicating
that loss of PEX10 has its most pronounced effect on
peroxisomal matrix-protein import.
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Introduction
Peroxisomes, which are present in almost all eukaryotic
cells, are single-membrane–bound organelles that par-
ticipate in numerous metabolic processes (Lazarow and
Fujiki 1985). In humans, these processes include b-ox-
idation of fatty acids; synthesis of bile acids, cholesterol,
and plasmalogens; and a variety of H2O2-producing ox-
idation reactions (van den Bosch et al. 1992). The en-
zymes responsible for these functions are encoded by
nuclear genes, synthesized on cytoplasmic ribosomes,
and posttranslationally imported into peroxisomes (La-
zarow and Fujiki 1985). The import process, which is
conserved from yeast to humans (Gould et al. 1990), is
mediated by cis-acting peroxisome-targeting signals
(PTS). For peroxisomal matrix proteins, import is most
commonly specified by the type-1 PTS (PTS1), which
consists of a C-terminal tripeptide of the sequence Ser-
Lys-LeuCOOH (SKLCOOH) or a conservative variant (Gould
et al. 1989; Subramani 1993). Less commonly used is
the PTS2, a 9-amino-acid signal located near the amino
terminus of proteins with a consensus sequence RLX5H/
QL (Subramani 1993; Swinkels et al. 1991). Although
peroxisomal membrane proteins also contain cis-acting
sequence elements that target them to peroxisomes (Dyer
et al. 1996), a consensus sequence has yet to be
established.
The identification of trans-acting components of the
peroxisomal protein import machinery has relied heavily
on genetic screens and selections in yeast. These studies
have identified at least 16 different genes (PEX) and gene
products (peroxins) that are required for peroxisome bi-
ogenesis and normal matrix-protein import (Distel et al.
1996; Albertini et al. 1997; Eitzen et al. 1997) (S.J.G.,
unpublished results). Information derived from studying
yeast pex mutants, which have a defect in the import of
one or more classes of peroxisome matrix proteins, has
shaped our understanding of peroxisome protein import.
Import is thought to begin with two predominantly cy-
toplasmic receptors, PEX5 and PEX7, that recognize
newly synthesized proteins that contain a PTS (Mc-
Collum et al. 1993; Marzioch et al. 1994; Dodt et al.
1995; Dodt and Gould 1996; Elgersma et al. 1996;
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Gould et al. 1996; Braverman et al. 1997). PEX5 binds
PTS1-containing proteins, whereas PEX7 binds PTS2-
containing proteins, and together these receptors direct
newly synthesized matrix proteins to the peroxisome.
The receptor-bound proteins are recognized by
membrane-anchored docking factors on the cytoplasmic
face of peroxisome membranes and subsequently are
translocated into the peroxisome matrix, presumably
through a membrane pore, although there is no evidence
yet for such a structure.
The peroxisome-biogenesis disorders (PBDs) are a ge-
netically heterogeneous group of lethal human diseases
that are caused by an inability to import peroxisomal
proteins (Lazarow and Moser 1995), the same pheno-
type displayed by yeast pex mutants. The PBDs include
Zellweger syndrome (ZS), neonatal adrenoleukodystro-
phy (NALD), infantile Refsum disease (IRD), and rhi-
zomelic chondrodysplasia punctata (RCDP) (Lazarow
and Moser 1995), and cell fusion studies have divided
the PBDs into 10 complementation groups (CGs) (Moser
et al. 1995). ZS, NALD, and IRD are characterized by
similar symptoms, with ZS representing the most severe
form and with NALD and IRD representing progres-
sively less severe phenotypic variants (Lazarow and
Moser 1995). Seven of the known CGs contain both
mildly and severely affected patients, suggesting that the
different phenotypes can result from mutations in the
same gene (Moser et al. 1995). The phenotype of clas-
sical RCDP patients, which all belong to CG11, is some-
what distinct from the phenotypic spectrum of ZS,
NALD, and IRD and is caused by defective import of
PTS2-containing proteins (Braverman et al. 1997; Mot-
ley et al. 1997; Purdue et al. 1997).
Given the conserved nature of the peroxisomal pro-
tein-import process (Gould et al. 1990), it is not sur-
prising that the PBDs are caused by mutations in human
orthologues of yeast PEX genes. This was first dem-
onstrated by the identification of human PEX5, the gene
mutated in PBD CG2 (Dodt et al. 1995; Wiemer et al.
1995), and has been confirmed by the identification of
human PEX1, PEX6, PEX7, and PEX12 as the genes
defective in CG1 (Portsteffen et al. 1997; Reuber et al.
1997), CG4 (Fukuda et al. 1996; Yahraus et al. 1996),
CG11 (Braverman et al. 1997; Motley et al. 1997; Pur-
due et al. 1997), and CG3 (Chang et al. 1997; Okumoto
and Fujiki 1997) of the PBDs, respectively. We report
here the cloning of the human orthologue of yeast
PEX10 and demonstrate that it is the gene defective in
CG7 of the PBDs.
Material and Methods
Cell Lines and Strains
Skin fibroblast cell lines were cultured in Dulbecco’s
modified Eagle’s medium (high glucose) supplemented
with 10% fetal bovine serum and penicillin/streptomycin
(Life Technologies-BRL), as described elsewhere (Slaw-
ecki et al. 1995). All PBD cell lines are referred to by
patient number and were obtained from Ann Moser
(Kennedy Krieger Institute, Baltimore). All bacterial ma-
nipulations were performed with Escherichia coli strain
DH10B.
Cloning of Human PEX10
PCR primers PEX10.1 (5′-AGG TTG AGC TGC TCT
CAG ATG TGG-3′) and PEX10.2 (5′-GAT GGG TCC
ACC GGA TGA TGC-3′) were designed from the se-
quence of EST H83562 and were used to amplify a 103-
bp fragment of the putative PEX10 cDNA from a human
muscle cDNA library (Clontech). This fragment, which
encodes the conserved TLGEEYV motif, was used to
probe a lZAP human fetal brain cDNA library (Stra-
tagene) at high stringency (Sambrook et al. 1989). Of
the 16 independent library clones that hybridized to the
PEX10 probe, 6 were sequenced from both ends of the
cDNA. The entire cDNA insert of one of the clones, 28-
2.3, was sequenced and was found to contain an open
reading frame (ORF) (GenBank accession number
AF060502) similar in size to those of the yeast PEX10
genes.
Plasmids
To generate the PEX10 cDNA expression plasmid
(cDNA-PEX10) a 1.1-kb NgoMI fragment, containing
the entire PEX10 ORF, was excised from cDNA clone
28-2.3, and the Klenow fragment of DNA polymerase
(Boehringer Mannheim) was used to make the overhangs
blunt. This fragment was ligated with pcDNA3 (Invi-
trogen) that had been digested with EcoRI and that had
been made blunt by means of the Klenow fragment. The
PEX10myc cDNA was created by amplification of the
PEX10 ORF (lacking its stop codon), with the primers
PEX10myc5 (5′-CCC GGT ACC ATG GCC CCG GCC
GCC GCC AG-3′) and PEX10myc3 (5′-CCC GGA TCC
GCG GTA GTG CCG AAG GTA G-3′). The resulting
fragment was cleaved with Asp718 and BamHI and was
cloned in-frame with the myc-epitope-tag–encoding se-
quence in pcDNA3myc (Yahraus et al. 1996). The
pcDNA3-PEX10myc clone was sequenced, ensuring
that no errors were incorporated during PCR amplifi-
cation. PEX10 cDNA was synthesized from PBD052
and PBD100 RNA by reverse transcription (RT)–PCR
and was cloned into PCR 2.1 (Invitrogen), as described
in the “Mutation Analysis” section below. The three
mutant cDNAs identified in these patients were excised
by EcoRI restriction-endonuclease digestion and were
inserted into the EcoRI site of pcDNA3. The resulting
plasmids, pcDNA3-PEX10/H290Q, pcDNA3-PEX10/
R125ter, and pcDNA3-PEX10/PBD100, were used in
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the relative rescue experiments. pcDNA3-PEX10/
H290Q contains the entire PEX10 coding region, with
a single nucleotide change, a CrG transversion at nu-
cleotide 870 of the ORF, that results in the H290Q sub-
stitution. pcDNA3-PEX10/R125ter also carries the en-
tire PEX10 coding region, although a single nucleotide
change, a CrT transition at nucleotide 373 of the ORF,
results in a premature-termination codon, R125ter.
pcDNA3-PEX10/PBD100 carries a shortened form of
the PEX10 cDNA, which is missing 407 bp, nucleotides
194–600 of the ORF, from the middle of the coding
region. This fragment corresponds to the major PEX10
mRNA product of these cells. All PCR reactions were
performed with a low–error-rate mixture of polymerases
(Expand; Boehringer Mannheim).
Transfections, Indirect Immunofluorescence,
Antibodies, and Fluorescence Microscopy
Transfection was performed either by lipofection (Li-
pofectamine; Life Technologies-BRL) or by electropor-
ation, according to the protocol outlined by Chang et
al. (1997). Two days after transfection, the cells were
processed for immunofluorescence. The transfected cells
were fixed for 20 min in 3% formaldehyde/1 # Dul-
becco’s PBS solution (DPBS). After fixation, the cells
were washed 3 times in 1 # DPBS and were permea-
bilized by incubation in either 1% Triton X-100/1 #
DPBS (standard conditions) or 25 mg/ml digitonin/1 #
DPBS (for differential permeabilization experiments), for
5 min. To remove excess detergent, the cells were washed
three times in 1 # DPBS, which was followed by a 30-
min incubation with primary antibodies at the appro-
priate dilutions. The cells then were washed seven times
in 1 # DPBS and were incubated with the appropriate
secondary antibodies for 10 min. To remove excess sec-
ondary antibodies, the cells were washed seven times in
1 # DPBS and then were placed on glass slides in 10
ml of mounting solution (1 mg p-phenylenediamine/ml,
100 mM Tris pH 8.5, 90% glycerol). Anti-SKLCOOH an-
tibodies have been described elsewhere (Gould et al.
1990); anti-myc antibodies were obtained from Boeh-
ringer Mannheim; anti-catalase antibodies were ob-
tained from The Binding Site; secondary antibodies were
obtained from Jackson Immunochemicals; and anti-per-
oxisomal membrane protein 70 (PMP70) antibodies
were a generous gift from Dr. Suresh Subramani. Mi-
crographs were captured on an Olympus fluorescence
microscope.
Mutation Analysis
Genomic DNA was prepared by means of the
TurboGen kit (Invitrogen). RNA isolation and RT-PCR
was performed as described elsewhere (Michaud et al.
1992). The RT reactions were performed with Super-
script II (Life Technologies-BRL) and the PEX10.12
primer (5′-CAG CCA GGG ACA GCT TTC-3′). The
entire PEX10 ORF was amplified from PBD100,
PBD052, and control RNA samples by means of
PEX10.5 (5′-CTG TGC AAG CAA GGT TAA TC-3′)
and PEX10.7 (5′-GTG GCT GCT CGG GAC CAC-3′).
The products were T/A cloned into PCR2.1 (Invitrogen),
and multiple clones were sequenced. The mutations dis-
covered in cDNA clones were examined also by restric-
tion-endonuclease digestion of PCR-amplified genomic
DNA fragments of the PEX10 gene. Genomic DNA
from PBD052 and an unaffected individual was ampli-
fied by means of the primers PEX10.15 (5′-CGC TGC
ATG CCG TCC TGC CCT ACC-3′) and PEX10.22 (5′-
GCC CCT GAG CAG CCA CGC CCA CCT G-3′), and
this was followed by restriction digestion with BstEII, a
restriction-enzyme site introduced by the R125ter mu-
tation (allele A). Genomic DNA from PBD052 and an
unaffected individual also was amplified, by means of
the primers PEX10.18 (5′-CGT TTC CAG AAA CCC
CCT GTG CAC C-3′) and PEX10.24 (5′-CAC CAC
GCG GTG ATG CAC TCC CAG C-3′), and this was
followed by restriction-endonuclease digestion with
PvuII, a restriction-enzyme site introduced by the
H290Q mutation (allele B). The 407-bp deletion in
PEX10 cDNAs from PBD100 suggested an RNA pro-
cessing defect. We therefore performed a limited analysis
of PEX10 gene structure, and we found that the region
deleted from PBD100 PEX10 cDNAs corresponds to an
exon of the PEX10 gene. Sequence analysis of this exon
and flanking intronic sequences revealed the presence of
a GrA mutation at the splice-donor site of the down-
stream intron. Genomic DNA from PBD100 and an un-
affected individual was amplified by means of the prim-
ers PEX10.16 (5′-CCT GGA GCA GGA GCT GCA
GGC TGA C-3′) and PEX10.32 (5′-CCT TGA CAC
AGA TGC TGG ATG TAG AAC C-3′), which was fol-
lowed by restriction digestion with SnaBI, a restriction-
enzyme site destroyed by the GrA mutation.
Relative Rescue Experiments
For analysis of PEX10myc activity, PBD100 cells
were transfected with pcDNA3, pcDNA3-PEX10, and
pcDNA3-PEX10myc. Two days later, each cell popu-
lation was examined by indirect immunofluorescence, to
determine the percentage of cells importing anti-
SKL–reactive proteins into peroxisomes. To assess the
effect of the mutations in PBD052 and PBD100,
pcDNA3-PEX10/H290Q, pcDNA3-PEX10/R125ter,
pcDNA3-PEX10/PBD100, pcDNA3-PEX10, and
pcDNA3 each were cotransfected with pcDNA3
PAHXmyc, into PBD100 cells. Double indirect immu-
nofluorescence was performed 2 d later with anti-myc
and anti-catalase antibodies. The number of cells dis-
350 Am. J. Hum. Genet. 63:347–359, 1998
playing peroxisomal catalase staining was recorded for
each transfection, as were both the number of cells dis-
playing peroxisomal PAHXmyc staining and the total
number of cells that expressed PAHXmyc.
Results
Identification of Human PEX10
Pichia pastoris Pex10p (PpPex10p) is essential for per-
oxisomal matrix-protein import (Kalish et al. 1995) and
contains a C-terminal C3HC4 zinc-binding domain nec-
essary for PpPex10p function. To identify the human
PEX10 gene, we searched for human ESTs capable
of encoding proteins with significant similarity to
PpPex10p. However, these attempts were unsuccessful,
primarily because the only similarities detected were in
the C3HC4 domain, and we were unable to discern the
human PEX10 orthologue from the large number of
other C3HC4 proteins. Therefore, we modified our strat-
egy and instead searched for PEX10 orthologues in
other species. A screen of the nonredundant protein da-
tabases led to the identification of putative PEX10 ho-
mologues from Saccharomyces cerevisiae and Caenor-
habditis elegans (BLAST P values of 1.974 and 1.017,
respectively). We rescreened dbEST with the sequence of
PEX10 from C. elegans, an evolutionary relative closer
to humans, and identified one candidate human PEX10
cDNA (GenBank accession number H83562; clone
249368) that encoded a 7-amino-acid segment,
TLGEEYV. This sequence is present in the P. pastoris
(Kalish et al. 1995), Hansenula polymorpha (Tan et al.
1995), S. cerevisiae, and C. elegans PEX10 gene prod-
ucts but not in any other known protein. Unfortunately,
the sequence of clone 249368 did not correspond to the
sequence of EST H83562 deposited in GenBank. Thus,
we used primers based on the EST sequence to amplify
a 103-bp fragment of the candidate PEX10 cDNA from
a human muscle cDNA library. This fragment contains
the TLGEEYV motif and was used to probe a human
fetal brain cDNA library. The fragment was amplified
and was used to probe a human fetal brain cDNA li-
brary. Multiple PEX10 cDNA clones were identified and
sequenced, and one contained an ORF that encodes a
protein that is similar in size to the previously identified
yeast PEX10 proteins. An alignment between the pre-
dicted human PEX10 sequence and those of the P. pas-
toris, S. cerevisiae, and C. elegans PEX10 gene products
shows that the TLGEEYV region and the zinc-binding
domain are the most highly conserved regions of the
protein (fig. 1). Human PEX10 is predicted to have two
membrane-spanning domains, amino acids 51–67 and
219–239.
Human PEX10: A Peroxisomal Protein
To determine whether human PEX10 shared the per-
oxisomal membrane localization reported for yeast
PEX10 proteins (Kalish et al. 1995; Tan et al. 1995),
we created a modified version of the PEX10 cDNA en-
coding the 10-amino-acid c-myc epitope at the 3′ end of
the ORF (PEX10myc). PEX10myc was expressed in
normal human fibroblasts and was found to colocalize
with PMP70, a known integral peroxisome membrane
protein (Kamijo et al. 1990), demonstrating that human
PEX10 is a peroxisomal protein (fig. 2A and B).
Differential permeabilization experiments were used
to assess the topology of PEX10 in the peroxisome. Nor-
mal human fibroblasts were transfected with pcDNA3-
PEX10myc and, 2 d later, were processed for indirect
immunofluorescence by means of a technique in which
the cells were permeabilized with limiting amounts of
digitonin instead of with 1% Triton X-100. This treat-
ment permeabilizes the cell membrane while leaving per-
oxisome membranes intact, thus allowing antibodies to
bind cytoplasmic antigens but not intraperoxisomal an-
tigens. Double-labeling experiments with anti-myc (fig.
2C) and anti-SKL (fig. 2D) antibodies revealed that the
C-terminus of PEX10myc is exposed to the cytosol under
conditions that prevent detection of intraperoxisomal
SKL-containing proteins. Double-labeling experiments
with anti-myc (fig. 2E) and anti-PMP70 antibodies (fig.
2F), which bind the cytoplasmic tail of PMP70, dem-
onstrated colocalization of PEX10myc and PMP70 un-
der these conditions, confirming that the punctate dis-
tribution of PEX10myc staining (as seen in fig. 2C)
corresponds to peroxisomes and that peroxisomes re-
main intact during treatment with digitonin. These re-
sults indicate that PEX10 is a peroxisomal membrane
protein with its C-terminus oriented toward the
cytoplasm.
Accordingly, PEX10 should localize to peroxisomes
in cell lines that do not import matrix proteins but that
do import peroxisomal membrane proteins. One such
cell line is PBD062, which lacks functional PEX2 (Shi-
mozawa et al. 1992; Chang et al. 1997). PBD062 cells
were transfected with pcDNA3-PEX10myc and were
processed for double indirect immunofluorescence with
anti-myc and anti-PMP70 antibodies. The colocalization
of PEX10myc (fig. 2G) with PMP70 (fig. 2H) in these
cells demonstrated that the targeting of human PEX10
to peroxisomes is independent of the matrix-pro-
tein–import machinery and provides additional evidence
that PEX10 is a peroxisomal membrane protein.
Expression of PEX10: Restoration of Import in CG7
Cell Lines
Given that PpPex10p is required for peroxisome bi-
ogenesis, it is likely that mutations in human PEX10
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Figure 1 Alignment of deduced Homo sapiens, C. elegans, S. cerevisiae, and P. pastoris PEX10 gene products. Sequence alignment was
performed by means of MegAlign/DNASTAR. Blackened letters denote identical amino acids present in at least two of the four proteins; and
asterisks (*) indicate the zinc-binding residues of the C3HC4 domain. The putative S. cerevisiae PEX10 gene (YDR265W) is more similar to
PpPEX10 than is any other gene of this species, and C. elegans PEX10 (GenBank accession number U10402) is the only gene in this species
with significant similarity to PpPEX10.
would result in ZS or a related PBD phenotype. To test
this possibility, the human PEX10 cDNA was expressed
in skin fibroblasts from patients representing CG7, CG9,
and CG12 of the PBDs, each of unknown genetic eti-
ology. PEX10 expression restored peroxisomal matrix-
protein import in fibroblasts from CG7 but not in cells
from the other CGs. Prior studies of three CG7 cell lines,
all from NALD patients, revealed mild cellular defects
associated with significant import of PTS1 and PTS2
proteins and even import of PEX5, the PTS1 receptor
(Slawecki et al. 1995; Dodt and Gould 1996). However,
we have since identified multiple ZS patients who belong
to CG7. Cells from one such patient, PBD100, fail to
import PTS1 or PTS2 matrix proteins but contain per-
oxisomes that are capable of importing peroxisomal
membrane proteins (fig. 3A–C). Expression of PEX10
in PBD100 cells restores import of both PTS1 and PTS2
proteins into peroxisomes (fig. 3D and E). Colocaliza-
Figure 2 PEX10, a peroxisomal protein with its C-terminus exposed to the cytoplasm. Normal human skin fibroblasts (5756-T) were
transfected with pcDNA3-PEX10myc. The cells were fixed, permeabilized with 1% Triton X-100, and processed for double indirect immu-
nofluorescence with use of both a monoclonal antibody specific for the 10-amino-acid myc epitope tag and rabbit antibodies specific for PMP70,
and this was followed by incubation with fluorescein-labeled goat anti-mouse and Texas red–labeled goat anti-rabbit secondary antibodies.
Colocalization of PEX10myc (A) and PMP70 (B) in cells that were fixed and permeabilized with Triton X-100 shows that PEX10 is a peroxisomal
protein. To assess PEX10 topology, 5756-T cells were transfected with pcDNA3-PEX10myc, were fixed, and were permeabilized with 25 mg
digitonin/ml, which permeabilizes the cell membrane but leaves the peroxisome membrane intact. One set of these cells was processed for double
indirect immunofluorescence with use of anti-myc (C) and anti-SKL (D) antibodies, and this was followed by incubation with fluorescein-labeled
goat anti-mouse and Texas red–labeled goat anti-rabbit secondary antibodies. Another set of these cells was processed for double indirect
immunofluorescence with use of anti-myc (E) and anti-PMP70 (F) antibodies, and this was followed by incubation with fluorescein-labeled goat
anti-mouse and Texas red–labeled goat anti-rabbit secondary antibodies. PBD062 cells also were transfected with pcDNA3-PEX10myc and
were processed for double indirect immunofluorescence under standard permeabilization conditions (Triton X-100), with use of anti-myc (G)
and anti-PMP70 (H) antibodies, and this was followed by incubation with fluorescein-labeled goat anti-mouse and Texas red–labeled goat anti-
rabbit secondary antibodies.
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Figure 3 Functional complementation in PBD100 cells. To assess PTS1 import, PBD100 cells were transfected with pcDNA3 (A) or
pcDNA3-PEX10 (D) and were processed for indirect immunofluorescence with use of rabbit antibodies specific for SKL-containing proteins
and fluorescein-labeled goat anti-rabbit secondary antibodies. To assess PTS2 import, PBD100 cells were cotransfected with both pcDNA3-
PAHXmyc, a plasmid designed to express a c-myc–tagged version of the PTS2 protein phytanoyl-CoA a-hydroxylase (Mihalik et al. 1997),
and either pcDNA3 (B) or pcDNA3-PEX10 (E and F). Cells transfected with pcDNA3 and pcDNA3-PAHXmyc were processed for indirect
immunofluorescence with use of a monoclonal antibody directed against the 10-amino-acid myc epitope tag and fluorescein-labeled goat anti-
mouse secondary antibodies. Cells transfected with pcDNA3-PEX10 and pcDNA3-PAHXmyc were processed for double indirect immunoflu-
orescence with use of antibodies specific for the myc epitope tag (E) and PMP70 (F), and this was followed by incubation with fluorescein-
labeled goat anti-mouse and Texas red–labeled goat anti-rabbit secondary antibodies. C, PBD100 cells transfected with pcDNA3, processed for
indirect immunofluorescence with use of rabbit antibodies specific for PMP70 and Texas red–labeled goat anti-rabbit secondary antibodies,
demonstrating the presence of numerous PMP-containing peroxisomes in the absence of PEX10.
tion (fig. 3E and F) and selective permeabilization (data
not shown) experiments confirmed that the punctate dis-
tribution of peroxisomal matrix proteins in transfected
cells represents import into the peroxisome lumen.
In contrast to PBD100 cells, the mildly affected CG7
cell line PBD052 imports significant quantities of PTS1-
and PTS2-containing peroxisomal matrix proteins, as
has been described elsewhere (Slawecki et al. 1995). In
fact, peroxisomal matrix-protein import in these cells is
so high that it was difficult to assess rescue of this cell
line by following the distribution of SKL-containing
PTS1 proteins or the PTS2 marker-protein PAHX-myc
(fig. 4A and B). However, peroxisomal catalase, which
carries an unusual form of PTS1 (Purdue and Lazarow
1996) and is the most inefficiently imported mammalian
protein known ( time of import  15 min) (Lazarow12
et al. 1982), was found to be cytosolic in these cells.
Transfection of PBD052 cells with the PEX10 expres-
sion vector rescued catalase import in these cells (fig. 4C
and D), suggesting that this cell line is also defective in
PEX10.
Having established that expression of an unmodified
PEX10 cDNA restored peroxisome matrix-protein im-
port in CG7 cells, we were able to test the effect of the
C-terminal myc tag on PEX10 function. PBD100 cells
were transfected with either pcDNA3, pcDNA3-PEX10,
or pcDNA3-PEX10myc and were processed for indirect
immunofluorescence, with use of rabbit antibodies spe-
cific for SKLCOOH-containing proteins. PEX10myc ex-
pression restored peroxisomal protein import in PBD100
cells (54%) as efficiently as the wild-type PEX10 cDNA
(56%) (table 1), demonstrating that PEX10myc is a
functional form of PEX10 (note that rescue activities are
limited by transfection efficiency).
CG7 Patients’ Mutations in PEX10
PEX10 cDNAs containing the entire PEX10 ORF
were synthesized from PBD100 and PBD052 RNA sam-
ples by RT-PCR. The PEX10 cDNA from ZS patient
PBD100 was ∼400 bp shorter than normal. Analysis of
genomic DNA clones from PBD100 and controls re-
vealed that this patient has a GrA transition mutation
at the splice-donor site (GTrAT) in an intron that lies
downstream from a 407-bp exon. The sequence of this
exon corresponds to the 407 bp that are missing from
PBD100 PEX10 cDNAs, suggesting that the mutation
causes aberrant mRNA processing and leads to exon
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Table 1
Expression of PEX10myc: Restoration of PTS1 Protein
Import in PBD100 Cells
Transfected Plasmid
Proportion (%) of PBD100 Cells
Importing PTS1 Proteins
pcDNA3 0/210
pcDNA3 PEX10 122/217 (56)
pcDNA3 PEX10myc 166/306 (54)
Figure 4 Functional complementation in PBD052 cells. PBD052 cells were transfected with pcDNA3, processed for indirect immunoflu-
orescence with use of rabbit antibodies specific for SKL-containing proteins and fluorescein-labeled goat anti-rabbit secondary antibodies (A).
Note the significant import of SKL-reactive proteins into punctate structures. PBD052 cells were cotransfected with pJM282, the PAHXmyc
expression vector, and pcDNA3, processed for indirect immunofluorescence with use of a monoclonal antibody directed against the 10-amino-
acid myc epitope tag and fluorescein-labeled goat anti-mouse secondary antibodies, revealing significant import of PAHXmyc, the PTS2 marker
protein (B). PBD052 cells transfected with pcDNA3 (C) or pcDNA3-PEX10 (D) were processed for indirect immunofluorescence with use of
sheep antibodies specific for peroxisomal catalase and rhodamine-labeled donkey anti-sheep secondary antibodies, demonstrating rescue of this
mildly affected line by expression of PEX10.
skipping. It also should be noted that this mutation cor-
responds to a CrT transition at a CpG dinucleotide on
the antisense strand. The homozygous nature of this al-
lele, which destroys a SnaBI site, was confirmed by re-
striction-endonuclease digestion of an amplified genomic
DNA fragment spanning this mutation (fig. 5B).
In contrast to PBD100, cells from NALD patient
PBD052 express full-length PEX10 mRNA. Sequence
analysis of PEX10 cDNA clones from this patient re-
vealed two distinct alleles, indicating that this patient is
a compound heterozygote. One PEX10 mutation, a
CrT transition at a CpG dinucleotide (fig. 5C), converts
the Arg125 codon to a stop codon (R125ter). The other
PEX10 mutation, a CrG transversion (fig. 5D), results
in a substitution of glutamine for the zinc-coordinating
histidine (H290) of the C3HC4 zinc ring domain and was
found on 190% (54/59) of the PEX10 cDNA clones
generated from this patient. This histidine is conserved
in PEX10 from all species that have been examined. The
low number of PBD052 PEX10 cDNA clones that carry
the R125ter mutation is consistent with a decreased
abundance of the corresponding mRNA, a decrease that
may be caused by nonsense-mediated RNA decay (Ma-
quat 1995). Both mutations create new restriction-en-
zyme sites, and the presence of both mutations was con-
firmed at the genomic level by restriction-endonuclease
digestion of amplified genomic DNA fragments of the
PEX10 gene (fig. 5C and D).
Relative Activity of PEX10 Alleles from PBD052 and
PBD100
Having established that expression of the normal
PEX10 cDNA restores PTS1 and PTS2 import in
PBD100 cells, we wanted to determine the relative in
vivo activity of the mutant PEX10 cDNAs identified in
PBD100 and PBD052. The corresponding expression
vectors—pcDNA3-PEX10/H290Q, pcDNA3-PEX10/
R125ter, and pcDNA3-PEX10/PBD100—were cotrans-
fected with pcDNA3-PAHXmyc, which encodes a myc-
tagged PTS2 protein, into PBD100 cells. pcDNA3-
Figure 5 PEX10 cDNA sequence and mutations in PBD100 and PBD052. A, Nucleotide and amino acid sequence of the PEX10 gene.
Nucleotides of the ORF are capitalized and numbered from the first nucleotide of the ORF; untranslated sequences are in lowercase; the segment
lacking in PEX10 cDNAs from PBD100 is underlined; and asterisks (*) indicate the sites of the H290Q and the R125ter mutations in PBD052.
B, Mutation in PBD100, a GrA transition at a splice-donor site, which destroys a SnaBI site. The sequence to the left shows the exon/intron
boundary at the site of the mutation in control and PBD100 genomic DNA samples. Intronic sequences are in lowercase. A 398-bp fragment
of the PEX10 gene flanking this site was amplified from the genomic DNA of an unaffected individual and from PBD100, was digested with
SnaBI, and was separated on a 3% agarose gel. DNA amplified from an unaffected individual (lane 1) was digested completely with SnaBI,
whereas the DNA amplified from PBD100 (lane 2) was resistant to digestion, indicating that PBD100 is homozygous for this mutation. Note
that this point mutation causes a 407-bp deletion in the PEX10cDNA. C, PBD052 allele A (R125ter), a CrT transition at nucleotide 373 of
the ORF, which creates a BstEII site. A 133-bp fragment spanning the site of this mutation was amplified from the genomic DNA of an
unaffected individual and from PBD052, was digested with BstEII, and was separated on a 4% agarose gel. DNA amplified from a normal
individual (lane 1) was resistant to digestion with BstEII, whereas ∼50% of the DNA amplified from PBD052 (lane 2) is cleaved into two
smaller fragments, suggesting that PBD052 is not homozygous for this mutation. D, PBD052 allele B (H290Q), a CrG transversion at nucleotide
870 of the ORF, which creates a PvuII site. A 105-bp fragment spanning the site of this mutation was amplified from genomic DNA of an
unaffected individual and from PBD052, was digested with PvuII, and was separated on a 4% agarose gel. The fragment from the unaffected
individual was resistant to digestion with PvuII (lane 1), whereas ∼50% of the DNA amplified from PBD052 (lane 2) is cleaved into two smaller
fragments, indicating that PBD052 is a compound heterozygote.
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Table 2
Relative Rescue Activities of Control and Mutant PEX10
cDNAs in PBD100 Cells
TRANSFECTED PLASMID
PROPORTION (%) OF CELLS IMPORTING
PTS1 Proteins PTS2 Proteins
pcDNA3 0/1,000 37/507 (7.3)
pcDNA3-PEX10/PBD100 0/1,000 54/505 (10.7)
pcDNA3-PEX10/H290Q 273/1,000 (27.3) 444/506 (87.7)
pcDNA3-PEX10/R125ter 291/1,000 (29.1) 450/501 (89.8)
pcDNA3-PEX10 631/1,000 (63.1) 449/507 (88.6)
PEX10 and pcDNA3 also were cotransfected with
pcDNA3-PAHXmyc, as positive and negative controls,
respectively. Each transfected cell population was pro-
cessed for double indirect immunofluorescence with
anti-myc and anti-catalase antibodies, and the number
of cells importing PTS1 and PTS2 proteins was recorded.
These experiments were repeated three times, and similar
results were obtained in each instance. The data from a
representative trial are shown in table 2. We found that
cells transfected with pcDNA3-PEX10/PBD100 do not
import PTS1 or PTS2 proteins above background levels,
consistent with the severe clinical and cellular defects of
PBD100. In contrast, pcDNA3-PEX10/H290Q and
pcDNA3-PEX10/R125ter rescued PTS2 protein import
as efficiently as did pcDNA3-PEX10 and restored im-
port of catalase, a PTS1 protein, to almost 50% of the
level observed for pcDNA3-PEX10. These results indi-
cate that both PBD052 alleles, when overexpressed, have
significant PEX10 activity. However, it should be noted
that the consistent underrepresentation of the R125ter
allele in RT-PCR reactions (data not shown) indicates
that this mutation may affect mRNA abundance.
Discussion
Defects in peroxisomal protein import have long been
implicated in the PBDs, but for many years there was
little progress in the elucidation of the molecular and
genetic basis of these diseases. However, the advent of
the EST projects, the identification of many yeast pro-
teins required for peroxisome biogenesis, and the con-
served nature of peroxisomal protein import have aided
the identification of the genes defective in the PBDs. Prior
to this report, the genes defective in five of the known
CGs of the PBDs, comprising 180% of all PBD patients
(Reuber et al. 1997), had been identified. Here we extend
our knowledge of the genetic etiology of these diseases,
with the identification of human PEX10 as the gene
mutated in patients from CG7 of the PBDs.
PEX10 expression rescues the peroxisomal protein
import defects of cells from CG7 patients. We have
found mutations on both copies of PEX10 from two of
these patients, PBD052 and PBD100, and currently are
searching for PEX10 mutations in the remaining CG7
patients. PBD100, a severely affected ZS patient and the
progeny of a consanguineous marriage, is homozygous
for a splice donor–site mutation in one of the introns
of the PEX10 gene and produces truncated PEX10
mRNAs, most of which lack all of a 407-bp coding exon.
We were unable to detect significant matrix-protein im-
port in PBD100 cells, and the PEX10 cDNA generated
from PBD100 RNA lacked activity, even when overex-
pressed at high levels. This suggests that the splice-site
mutation in PBD100 creates a null allele of PEX10.
PBD052, the second CG7 patient whom we have char-
acterized at the molecular level, is a compound heter-
ozygote for PEX10 mutations. PBD052 displays mild
clinical and cellular phenotypes, suggesting that one of
the corresponding alleles would express at least some
PEX10 activity. Given that the two mutations are a mis-
sense mutation (H290Q) at a zinc-coordinating histidine
residue of the zinc-binding domain and a nonsense mu-
tation (R125ter) predicted to terminate translation after
synthesis of only the N-terminal third of PEX10, we
assumed that the residual activity would be derived from
the allele with the H290Q mutation. However, we ob-
served that PEX10 cDNAs containing either the H290Q
mutation or the R125ter mutation displayed extremely
high levels of activity in an in vivo functional comple-
mentation assay.
A prior study of yeast PEX10 had demonstrated that
mutations at any of three zinc-binding residues of the
C3HC4 domain, including the sole zinc-binding histidine
H315, inactivated this gene in a functional complemen-
tation assay (Kalish et al. 1995). The fact that substi-
tutions for H315 of yeast Pex10p (H315W), as well as
for the analogous residue of human PEX10, H290
(H290Q), have phenotypic consequences lends support
to the hypothesis that the zinc-binding domain is im-
portant for PEX10 function. However, the consequences
of the H315W and H290Q mutations appeared to differ,
with the H315W mutation inactivating the yeast PEX10
gene (Kalish et al. 1995) whereas the H290Q mutation
results in only an attenuation of PEX10 activity. Al-
though it is possible that the threshold for activity in the
yeast and human functional complementation assays is
different, it is also possible that the nature of the sub-
stitution is responsible for the apparently severe conse-
quences of the H315W substitution and for the mild
consequences of the H290Q mutation. One possible dif-
ference is that glutamine may participate in coordination
of metal ions indirectly through a water molecule, an
activity that would not be expected for tryptophan.
Although the consequence of the H290Q mutation
was unexpectedly mild, the high activity of the PEX10/
R125ter cDNA was even more surprising. The deduced
product of this allele includes only the N-terminal 124
amino acids of PEX10, a region that contains both the
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first putative transmembrane domain of the protein and
the TLGEEYV motif. If this is indeed the only product
of the R125ter allele, it would mean that the second
transmembrane domain and the zinc-binding domain
can be removed without elimination of PEX10 activity,
a result that again conflicts with the inactivating effect
of missense mutations in the zinc-binding domain of
yeast PEX10. However, it is also possible that additional
PEX10 products are synthesized from the R125ter
cDNA, which may contribute to the PEX10 activity of
pcDNA-PEX10/R125ter. Although elucidation of the
mechanism responsible for PEX10/R125ter activity is
important for an understanding of the role of PEX10
in peroxisome biogenesis, we doubt that the R125ter
allele contributes significant PEX10 activity to PBD052
cells. The R125ter mutation was present in !10% of
PBD052 PEX10 cDNAs, suggesting that this mRNA ex-
ists at reduced abundance in these cells. The R125ter
mutation lies within the fourth-to-last coding exon of
the PEX10 gene (data not shown), and nonsense-me-
diated mRNA decay has been shown to affect steady-
state mRNA levels of genes carrying frameshift or non-
sense mutations in exons upstream from the last two
coding exons (Maquat 1995).
Peroxisomal matrix-protein import is a multistep pro-
cess that requires at least 16 different proteins. For PTS1
proteins, import appears to begin with recognition by
the PTS1 receptor (PEX5) in the cytoplasm and subse-
quent transport of the receptor-ligand complex to the
peroxisome surface (Dodt and Gould 1996). There the
receptor binds via membrane-bound docking factors (El-
gersma et al. 1996; Erdmann and Blobel 1996; Gould
et al. 1996; Albertini et al. 1997), followed by trans-
location of matrix proteins and recycling of the receptor
to the cytoplasm (Dodt and Gould 1996). van der Klei
et al. (1995) have reported that H. polymorpha PEX5
is present in the cytoplasm, peroxisome membrane, and
peroxisome matrix, suggesting that PEX5 may be im-
ported along with its cargo of newly synthesized per-
oxisomal proteins and may be exported to the cytosol
after dissociation from its ligands. Previous studies on
human fibroblasts have demonstrated that PEX5 is also
imported into the peroxisome lumen in certain mildly
affected CG7 cell lines, including PBD052, which display
relatively high levels of matrix-protein import (Dodt and
Gould 1996). Although these earlier observations were
consistent with a role for the CG7 gene in PEX5 export,
we have found that PBD052 cells express alleles of
PEX10 that retain significant activity. Also, we now
know that other CG7 cells with severe mutations in
PEX10, such as PBD100, are associated with both a
complete block in matrix-protein import and accumu-
lation of PEX5 on the outer surface of peroxisomes (data
not shown). The observation that PEX5 import occurs
in cells with partial PEX10 function (PBD052) and not
in cells that completely lack PEX10 function (PBD100)
argues against a role for this protein in receptor export.
Instead, our data are consistent with a role for PEX10
in either the translocation of matrix proteins across the
peroxisome membrane or in receptor-ligand dissociation
prior to the translocation event. As such, it would appear
that one or the other PBD052 alleles disrupts the spec-
ificity and/or efficiency of the translocation process.
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